Additionally, CYP2A6 genetic variants are associated with lung cancer in a recent GWAS (Transdisciplinary Research in Cancer of the Lung (TRICL) consortium), even when controlling for smoking duration and quantity [44]. Here, CYP2A6 is linked to lung carcinoma.